Skip to main content
  1. Right Decisions
  2. Neurology pathways
  3. Back
  4. Headache
  5. 4. Access to Image in Headache
Announcements and latest updates

Right Decision Service newsletter: April 2024

Welcome to the Right Decision Service (RDS) newsletter for April 2024. 

Issues with RDS and Umbraco access

Tactuum has been working hard to address the issues experienced during the last week. They have identified a series of three mitigation measures and put the first of these in place on Friday 3rd May.  If this does not resolve the problems, the second mitigation will be actioned, and then the third if necessary.

Please keep a lookout for any slowing down of the system or getting locked out. Please email myself, mbuchner@tactuum.com and onivarova@tactuum.com if you experience any problems, and also please raise an urgent support ticket via the Support Portal.

Thank you for your patience and understanding while we achieve a full resolution.

Promotion and communication resources

A rotating carousel presenting some of the key RDS tools and capabilities, and an editable slideset, are now available in the Resources for RDS providers section of the Learning and Support toolkit.

Redesign and improvements to RDS

The redesign of RDS Search and Browse is still on-track for delivery by mid-June 2024. We then plan to have a 3-week user acceptance testing phase before release to live. All editors and toolkit owners on this mailing list will be invited to participate in the UAT.

The archiving and version control functionality is also progressing well and we will advise on timescales for user acceptance testing shortly.

Tactuum is also progressing with the deep linking to individual toolkits within the mobile RDS app. There are several unknowns around the time and effort required for this work, which will only become clear as the work progresses. So we need to be careful to protect budget for this purpose.

New feature requests

These have all been compiled and effort estimated. Once the redesign work is complete, these will be prioritised in line with the remaining budget. We expect this to take place around late June.

Evaluation

Many thanks to those of you completed the value and impact survey we distributed in February. Here are some key findings from the 65 responses we received.

Figure 1: Impact of RDS on direct delivery of care

Key figures

  • 93% say that RDS has improved evidence-informed practice (high impact 62%; some impact 31%)
  • 91% report that RDS has improved consistency in practice (high impact 65%, some impact 26%)
  • 85% say that RDS has improved patient safety (high impact 59%, some impact 26%)
  • Although shared decision-making tools are only a recent addition to RDS, and only represent a small proportion of the current toolset, 85% of respondents still said that RDS had delivered impact in this area (53% high impact, 32% some impact.) 92% anticipate that RDS will deliver impact on shared decision-making in future and 85% believe it will improve delivery of personalised care in future.

Figure 2 shows RDS impact to date on delivery of health and care services

 

Key figures

These data show how RDS is already contributing to NHS reform priorities and supporting delivery of more sustainable care.

Saving time and money

  • RDS clearly has a strong impact on saving practitioner time, with 90% of respondents reporting that this is the case. 65% say it has a high impact; 25% say it has some impact on time-saving.
  • It supports devolved decision-making across the multi-professional team (85% of respondents)
  • 76% of respondents confirm that it saves money compared, for example, to investing in commercial apps (54% high impact; 22% some impact.)
  • 72% believe it has impacted already on saving money and reducing waste in the way services are delivered – e.g. reducing costs of referral management, prescribing, admissions.

Quality assurance and governance

  • RDS leads are clear that RDS has improved local governance of guidelines, with 87% confirming that this is the case. (62% high impact; 25% some impact.)

Service innovation and workforce development

  • RDS is a major driver for service innovation and improvement (83% of respondents) and has impacted significantly on workforce knowledge and skills (92% of respondents – 66% high impact; 26% some impact).

New toolkits

A few examples of toolkits published to live in the last month:

Toolkits in development

Some of the toolkits the RDS team is currently working on:

  • SARCS (Sexual Assault Response Coordination Service)
  • Staffing method framework – Care Inspectorate.
  • SIGN 171 - Diabetes in pregnancy
  • SIGN 158 – British Guideline on Management of Asthma. Selected sections will be incorporated into the RDS, and complemented by a new chronic asthma pathway being developed by SIGN, British Thoracic Society and NICE.
  • Clinical pathways from NHS Fife and NHS Lanarkshire

Please contact his.decisionsupport@nhs.scot if you would like to learn more about a toolkit. The RDS team will put you in touch with the relevant toolkit lead.

Quality audit of RDS toolkits

Thanks to all of you who have responded to the retrospective quality audit survey and to the follow up questions.  We still have some following up to do, and to work with owners of a further 23 toolkits to complete responses. An interim report is being presented to the HIS Quality and Performance Committee.

Implementation projects

Eight clinical services and two public library services are undertaking tests of change to implement the Being a partner in my care app. This app aims to support patients and the public to become active participants in Realistic Medicine. It has a strong focus on personalised, person-centred care and a library of shared decision aids, as well as simple explanations and videoclips to help the public to understand the aims of Realistic Medicine.  The tests of change will inform guidance and an implementation model around wider adoption and spread of the app.

With kind regards

Right Decision Service team

Healthcare Improvement Scotland

Warning

Background

Most patients presenting to health services with headaches have primary headache (up to 95% presenting to primary care and over 50% presenting to A&E). The most common primary headache is migraine, making up the majority of these patients.  

Most patients with primary headache do not require investigation. Evidence based guidelines on neuroimaging in patients with non-acute headache estimate a rate of 0.2% of relevant intracranial abnormalities in patients diagnosed with migraine.  

Neuroimaging is often considered in patients with migraine for the following reasons: unusual, prolonged or persistent aura, increasing frequency severity or change in migraine clinical features, worst migraine, migraine with brainstem aura, hemiplegic migraine, migraine without aura.  

  

Neuroimaging is also, not uncommonly, carried out in patients for reassurance, both physician and patient. While some patients / clinicians may request neuroimaging hoping to ease anxiety, the initial reduction in anxiety is lost at 1 year follow up in patients with chronic headache. 

 

Apparently asymptomatic incidental abnormalities of potential significance are problematic and are an unintended consequence of brain imaging in clinical situations where the prevalence of any relevant finding is likely to be low. 

There is no evidence that imaging is more likely to reveal meaningful abnormalities in patients with primary headache compared to the general population. Several studies affirm that routine neuroimaging for migraine is more likely to identify incidental abnormalities than identify serious problems, potentially leading to more anxiety and leading to further investigations and follow up. 

 

The incidental abnormality pick-up rate on MRI scans can be up to 10%, with a chances of detecting an infarct in 1 in 14, aneurysm in 1 in 55 and a benign tumour such as a meningioma in 1 in 62. 

RED FLAGS

RED FLAGS 

Most patients do not have serious secondary headache. Red flags indicate the need for urgent assessment to exclude a secondary cause. The most consistent indicators for serious secondary causes for headache are: 

  1. Thunderclap (sudden onset) headache (consider SAH and its differential) 
  2. New focal neurological deficit on examination (e.g. hemiparesis) 
  3. Systemic features (considering GCA, infection such as meningitis or encephalitis, etc) 
  4. New progressive headache in a patient over 50 (most headaches presenting in patients over 50 are benign, but there is an increased risk of secondary pathology with increasing age) 

 

Headache suggesting the possibility of a brain tumour 

  1. New headache plus sub-acute progressive focal neurology 
  2. New headache plus seizures 
  3. New headache with personality or cognitive change not suggestive of dementia, with no psychiatric history and confirmed by witness 

AMBER FLAGS

Features that may indicate a secondary cause but may also be seen in primary headaches: 

  1. Changes in headache intensity with changes of posture (upright consider low pressure / headache when lying flat consider high pressure) 
  2. Worsening/Triggering headache with Valsalva (e.g. coughing, straining) 
  3. Atypical aura (duration >1 hour or including motor weakness) 
  4. Progressive headache (worsening over weeks or longer) 
  5. Head trauma within the last month 
  6. Previous history of cancer or HIV 
  7. Re-attendance to A&E or GP surgery with progressively worsening headache severity or frequency 

Consider a secondary cause if any of these are present 

 

Features that do not help to differentiate primary from secondary headaches are: 

  1. Severity  
  2. Treatment response  

GREEN FLAGS

Features that are supportive of a diagnosis of primary headache: 

  1. Recurrent episodic headache, particularly with features of migraine 
  2. Long history of daily headache 

If there are no concerning features then it is appropriate to manage these patients for migraine. Other features that are pointers to migraine include a previous migraine history and a family history of migraine. 

GP open access CT scan

GP open access CT scan for Headache (where available) should be available for: 

  • Adult patients above the age of 16 years 
  • No red flags  
  • Normal neurological examination 

Patients should not be routinely imaged for migraine 

Patients with red flags should be referred as emergency / urgently to secondary care for appropriate assessment / investigation 

Patients with amber flags should be considered for urgent referral to secondary care for investigations, unless the primary care physician decides that a GP open access CT is more appropriate 

Referral to secondary care for open access CT brain imaging

If there is diagnostic uncertainty or concern about a secondary cause, at this point consider open access CT as an alternative to secondary referral. For some patients, CT may not be the most appropriate investigation e.g. ESR/CRP/Plasma viscosity in GCA and LP (after appropriate imaging) in Idiopathic Intracranial Hypertension. 

Dealing with incidental findings from CT and MRI scans 

There must be a clear local pathway for management of patients who have an abnormality detected on their GP open access CT scan.  

Evidence base – MRI in the general population 

The overall prevalence of incidental brain findings in 2000 asymptomatic volunteers aged 46-97 using high resolution MRI was more than 10%. Asymptomatic brain infarcts were present in 7.2% and brain aneurysms in 1.8%. Benign tumours (mostly meningiomas) were present in 1.6%, arachnoid cysts in 1.1% and Chiari malformations in 0.9% 

 

A further metaanalysis subdivided incidental findings on MRI scans in 19559 participants into  

 

Potentially symptomatic or treatable abnormalities 

  • Neoplasms 
  • Cysts 
  • Structural vascular abnormalities 
  • Inflammatory lesions 
  • Others – chiari malformations, neoplasms 

  

Markers of cerebrovascular disease 

  • White matter abnormalities 
  • Silent brain infarcts 
  • Brain microbleeds 

 

The meta-analysis reported an incidental abnormality pickup rate of 1.7% using low resolution MRI and 4.3% using high resolution MRI. The age range of patients was 3-97 which perhaps explained the lower pick up rate. They also reported an age related increase in white matter hyperintensities and brain infarcts and also in all neoplastic incidental brain findings. 

Evidence base – Neuroimaging in patients with migraine 

CT 

In a study of 1111 patients with headache who were scanned, 10.8% scans were abnormal, the majority in patients above the age of 40. This included 4% with a brain infarct and 1.6% with a primary neoplasm 

In a study looking at direct access CT brain scan for patients with a chronic headache, abnormal findings were reported in 10.5% 

 

MRI 

The HUNT study reported that patients with any headache disorder did not have a higher incidence of any intracranial abnormality as compared to the non-headache population except for non-specific white matter changes. 

Editorial Information

Last reviewed: 11/10/2023

Next review date: 01/04/2025